Details for 2023215946
Up to date per 12.05.2026
Actions
Details for 2023215946
Granted/Registered
European Patent
17.04.2024 A
15.04.2026 B1
19.10.2015
US
201562243505 P
12.05.2016
US
201662335311 P
G01N 33/68 20060101AFI20240429BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, OsakaJP
Representative
No representatives present
Inventor
SEXTON, Daniel J. Melrose, 02176US
FAUCETTE, Ryan Melrose, 02176US
COSIC, Janja Arlington, 02474US
Information about Fees